Henrietta Ukwu
Director/Board Member chez IBERE PHARMACEUTICALS
Profil
Henrietta Ukwu is an Independent Director at Ibere Pharmaceuticals.
She is also currently serving as the Chief Regulatory Officer & Executive VP at Novavax, Inc. Her former positions include Vice President-Global Regulatory Affairs & Policy at Merck & Co., Inc., Chief Regulatory Officer & Global Head-Quality at Otsuka America Pharmaceutical, Inc., Chief Regulatory Officer & Senior VP at Otsuka Holdings Co., Ltd., Senior VP & Head-Global Regulatory Affairs at PPD, Inc., and Vice President-Regulatory Affairs at Wyeth Pharmaceuticals, Inc. Dr. Ukwu holds a doctorate degree from the University of Jos.
Postes actifs de Henrietta Ukwu
Sociétés | Poste | Début |
---|---|---|
NOVAVAX, INC. | Corporate Officer/Principal | 15/01/2021 |
IBERE PHARMACEUTICALS | Director/Board Member | - |
Anciens postes connus de Henrietta Ukwu
Sociétés | Poste | Fin |
---|---|---|
OTSUKA HOLDINGS CO., LTD. | General Counsel | - |
PPD, INC. | General Counsel | - |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | General Counsel | - |
MERCK & CO., INC. | General Counsel | - |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | General Counsel | - |
Formation de Henrietta Ukwu
University of Jos | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
NOVAVAX, INC. | Health Technology |
OTSUKA HOLDINGS CO., LTD. | Health Technology |
Entreprise privées | 4 |
---|---|
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
PPD, Inc.
PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |
Ibere Pharmaceuticals
Ibere Pharmaceuticals Financial ConglomeratesFinance Ibere Pharmaceuticals is a blank check company, which was formed in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on October 22, 2020 and is headquartered in Philadelphia, PA. | Finance |